Prawo i regulacje · 29/01/2019

DEA Places MAB-CHMINACA in Schedule I, Imposing Strict Controls on Handling

The Drug Enforcement Administration has added N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, also known as MAB-CHMINACA, to Schedule I of the Controlled Substances Act, subjecting those who manufacture, distribute, or possess it to severe penalties and regulations.